Nicorandil in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Wu, Muli ^a   Huang, Zheng ^a   Xie, Haojun ^a   Zhou, Zhongjiang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; NICORANDIL; PLACEBO; ANTIARRHYTHMIC AGENT;

ACUTE HEART INFARCTION; ARTICLE; CONGESTIVE HEART FAILURE; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRACORONARY DRUG ADMINISTRATION; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; THROMBOLYSIS IN MYOCARDIAL INFARCTION FLOW GRADE; THROMBOLYSIS IN MYOCARDIAL INFARCTION FRAME COUNT; ARRHYTHMIAS, CARDIAC; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; FEMALE; FIBRINOLYTIC THERAPY; HEART FAILURE; HEART STROKE VOLUME; MALE; MEDLINE; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CLINICAL TRIALS AS TOPIC; FEMALE; HEART FAILURE; HUMANS; MALE; MYOCARDIAL INFARCTION; NICORANDIL; PERCUTANEOUS CORONARY INTERVENTION; PUBMED; RISK FACTORS; STROKE VOLUME; THROMBOLYTIC THERAPY;

EID: 84886006125     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078231     Document Type: Article

References (41)

1. ISIS 2 (Second International Study of Infarct Survival). Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2: 349-360.
2. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators (1997) A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 336: 1621-1628.
3. Kloner RA, (1993) Does reperfusion injury exist in humans? J Am Coll Cardiol 21: 537-545. doi:10.1016/0735-1097(93)90700-B. PubMed: 8426022.
4. Gross G, Pieper G, Farber NE, Warltier D, Hardman H, (1989) Effects of nicorandil on coronary circulation and myocardial ischemia. Am J Cardiol 63: 11-17. doi:10.1016/0002-9149(89)90199-9.
5. Pieper GM, Gross GJ, (1992) Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther 6: 225-232. doi:10.1007/BF00051143. PubMed: 1322163.
6. Nelson MT, Quayle JM, (1995) Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268: 799-822. PubMed: 7733230.
7. Imagawa J, Baxter GF, Yellon DM, (1998) Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J Cardiovasc Pharmacol 31: 74-79. doi:10.1097/00005344-199801000-00011. PubMed: 9456280.
8. Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, et al. (2005) Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 112: 1284-1288. doi:10.1161/CIRCULATIONAHA.104.530329. PubMed: 16116055.
9. Ono H, Osanai T, Ishizaka H, Hanada H, Kamada T, et al. (2004) Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J 148: 15-15. PubMed: 15459610.
10. Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, et al. (2007) Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet 370: 1483-1493. doi:10.1016/S0140-6736(07)61634-1. PubMed: 17964349.
11. Higgins JPT, Altman DG, Sterne AC, (2011) Chapter 8: Assessing risk of bias in included studies; Higgins JPT, Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011: 182-228.
12. Sweeting MJ, Sutton AJ, Lambert PC, (2004) What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 23: 1351-1375. doi:10.1002/sim.1761. PubMed: 15116347.
13. Miyazawa A, Ikari Y, Tanabe K, Nakajima H, Aoki J, et al. (2006) Intracoronary nicorandil prior to reperfusion in acute myocardial infarction. EuroIntervention 2: 211-217. PubMed: 19755263.
14. Toyama T, Seki R, Hoshizaki H, Kawaguchi R, Isobe N, et al. (2006) Nicorandil administration shows cardioprotective effects in patients with poor TIMI and collateral flow as well as good flow after AMI. Ann Nucl Med 20: 277-285. doi:10.1007/BF02984644. PubMed: 16856571.
15. Kawai Y, Hisamatsu K, Matsubara H, Dan K, Akagi S, et al. (2009) Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon. Eur Heart J 30: 765-772. PubMed: 19276198.
16. Han CL, Sung GA, Choi JH, Tae KL, Kim J, et al. (2008) Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction. Circ J 72: 1425-1429. doi:10.1253/circj.CJ-08-0212. PubMed: 18724016.
17. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, et al. (1999) Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 33: 654-660. doi:10.1016/S0735-1097(98)00604-4. PubMed: 10080465.
18. Fukuzawa S, Ozawa S, Inagaki M, Shimada K, Sugioka J, et al. (2000) Nicorandil affords cardioprotection in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angiosplasty: Assessment with thallium-201/iodine-123 BMIPP dual SPECT. J Nucl Cardiol 7: 447-453. doi:10.1067/mnc.2000.107273. PubMed: 11083193.
19. Nameki M, Ishibashi I, Miyazaki Y, Sakai Y, Namikawa S, et al. (2004) Comparison between nicorandil and magnesium as an adjunct cardioprotective agent to percutaneous coronary intervention in acute anterior myocardial infarction. Circ J 68: 192-197. doi:10.1253/circj.68.192. PubMed: 14993771.
20. Akagi T, Sarazawa K, Inai Y, Kitagawa M, Takahashi N, et al. (2006) Continuous administration of nicorandil decreases QT dispersion during the chronic phase of acute myocardial infarction. Int Heart J 47: 351-361. doi:10.1536/ihj.47.351. PubMed: 16823241.
21. Ota S, Nishikawa H, Takeuchi M, Nakajima K, Nakamura T, et al. (2006) Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART). Circ J 70: 1099-1104. doi:10.1253/circj.70.1099. PubMed: 16936418.
22. Atsuchi N, Yokoi H, Kamoi D, Hayashida K, Nakashima H, et al. (2007) Effects of nicorandil on left-ventricular remodeling after direct percutaneous coronary interventions in patients with ST-elevation myocardial infarction. J Am Coll Cardiol 49: 215-215.
23. Fujiwara T, Matsunaga T, Kameda K, Abe N, Ono H, et al. (2007) Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction. Heart Vessels 22: 303-309. doi:10.1007/s00380-007-0975-z. PubMed: 17879021.
24. Ishii H, Amano T, Imai K, Kokubo M, Yamada T, et al. (2004) Intravenous Nicorandil before percutaneous coronary intervention has pharmacological preconditioning effects in patients with acute myocardial infarction. Circulation 110: 106-106.
25. Lim YJ, Nanto S, Masuyama T, Kohama A, Hori M, et al. (1994) Myocardial salvage: its assessment and prediction by the analysis of serial myocardial contrast echocardiograms in patients with acute myocardial infarction. Am Heart J 128: 649-656. doi:10.1016/0002-8703(94)90260-7. PubMed: 7942434.
26. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, et al. (1992) Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85: 1699-1705. doi:10.1161/01.CIR.85.5.1699. PubMed: 1572028.
27. Akai K, Wang Y, Sato K, Sekiguchi N, Sugimura A, et al. (1995) Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. J Cardiovasc Pharmacol 26: 541-547. doi:10.1097/00005344-199510000-00006. PubMed: 8569213.
28. Takahashi K, Ohyanagi M, Kobayashi S, Iwasaki T, Miyamoto T, (2000) Effect of angiotensin-converting enzyme inhibitors and nitroxy groups on human coronary resistance vessels in vitro. J Cardiovasc Pharmacol 36: 417-422. doi:10.1097/00005344-200010000-00001. PubMed: 11026640.
29. Ozcan C, Bienengraeber M, Dzeja PP, Terzic A, (2002) Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol 282: 531-539. PubMed: 11788400.
30. Yasu T, Ikeda N, Ishizuka N, Matsuda E, Kawakami M, et al. (2002) Nicorandil and leukocyte activation. J Cardiovasc Pharmacol 40: 684-692. doi:10.1097/00005344-200211000-00006. PubMed: 12409977.
31. Niccoli G, Rigattieri S, De Vita MR, Valgimigli M, Corvo P, et al. (2013) Open-Label, Randomized, Placebo-Controlled Evaluation of Intracoronary Adenosine or Nitroprusside After Thrombus Aspiration During Primary Percutaneous Coronary Intervention for the Prevention of Microvascular Obstruction in Acute Myocardial Infarction: The REOPEN-AMI Study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction). JACC Cardiovasc Intv 6: 580-589. doi:10.1016/j.jcin.2013.02.009.
32. Sugimoto K, Ito H, Iwakura K, Ikushima M, Kato A, et al. (2003) Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction. Circ J 67: 295-300. doi:10.1253/circj.67.295. PubMed: 12655158.
33. Monassier JP, (2008) Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options. Arch. Cardiovasc Dis 101: 565-575. doi:10.1016/j.acvd.2008.06.013.
34. Hayat SA, Senior R, (2008) Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time? Eur Heart J 29: 299-314. doi:10.1093/eurheartj/ehm621. PubMed: 18245118.
35. Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, et al. (2002) Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 105: 1909-1913. doi:10.1161/01.CIR.0000014683.52177.B5. PubMed: 11997276.
36. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, et al. (2000) Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36: 1202-1209. doi:10.1016/S0735-1097(00)00865-2. PubMed: 11028471.
37. Nicolosi GL, Latini R, Marino P, Maggioni AP, Barlera S, et al. (1996) The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Eur Heart J 17: 1646-1656. doi:10.1093/oxfordjournals.eurheartj.a014747. PubMed: 8922912.
38. Ishii H, Ichimiya S, Kanashiro M, Amano T, Ogawa Y, et al. (2007) Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction. Am J Cardiol 99: 1203-1207. doi:10.1016/j.amjcard.2006.12.034. PubMed: 17478142.
39. Smith VM, Lyon CC, (2013) Results of an electronic survey of British Association of Dermatologists members: nicorandil ulceration. Br J Dermatol 168: 1136-1137. doi:10.1111/bjd.12199. PubMed: 23464596.
40. Robinson AJ, Stevenson JH, (2013) Discontinue treatment with nicorandil associated with ulceration to avoid major reconstructive surgery. BMJ 347: 4295-4295. doi:10.1136/bmj.f4295. PubMed: 23861409.
41. Suematsu Y, Murasato Y, Miura SI, Horiuchi M, Yamamoto T, et al. (2013) Safety and feasibility of high-dose administration of nicorandil before reperfusion therapy in acute myocardial infarction. Cardiovasc Interv Ther, 28(2013) Apr 27. [Epub ahead of print]. PubMed: 23625617.